
Chemical and Pharmaceutical Bulletin p. 501 - 510 (1999)
Update date:2022-08-03
Topics:
Ohkawa, Takehiko
Zenkoh, Tatsuya
Tomita, Masayuki
Hosogai, Naomi
Hemmi, Keiji
Tanaka, Hirokazu
Setoi, Hiroyuki
The present study was undertaken to evaluate whether a novel series of 2,6-diaza-5-oxobicyclo[5.4.0]undeca-1(7),8,10-triene derivatives exhibited antagonistic activity for vasopressin V1 and V2 receptors. Most of these compounds were
View MoreContact:+86-838-5655598
Address:Guanghan Nanfeng Industrial Zone
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
NANCHANG QINZHI SCI&TEC.CO.,LTD(expird)
Contact:+86-13687004106
Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
website:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Zhonghao (dalian) Research and Design Institute of Chemical Industry Co., Ltd
Contact:+86 411 84674606
Address:201, Huangpu Road , Shahekou District, Dalian ,116023-China
Doi:10.1016/0957-4166(95)00135-C
(1995)Doi:10.1021/ja01637a047
(1954)Doi:10.1021/ic00126a016
()Doi:10.1016/j.tetlet.2005.11.003
(2006)Doi:10.1246/cl.1995.459
(1995)Doi:10.1021/jo00120a036
(1995)